Skip to main content

Coronavirus Upends Marijuana Psychedelics And Drug Reform Ballot Measures

Former NFL player Kyle Turley believes CBD can prevent and cure coronavirus—and he’s not backing down on that clinically unsubstantiated claim despite pushback from marijuana legalization supporters and prohibitionists alike.

In fact, he accused those advocates of cowardice, alleging in an interview with Marijuana Moment that they’re afraid of the consequences of spreading what he claims is the “truth” about cannabis. He also said he would welcome Food and Drug Administration (FDA) enforcement against his CBD company over these COVID-19 claims and would use such an action as an opportunity to expose the government for covering up the medical potential of the plant.

In a series of tweets in recent weeks, Turley has repeatedly hawked CBD products, arguing that because the compound interacts with the endocannabinoid system, which plays some role in regulating the immune system, they can be used to prevent and cure coronavirus. He says he’s basing that take on anecdotal evidence, as well as conversations he said he’s had with experts in the field.

But the claim about a CBD coronavirus cure isn’t backed by clinical research. And at a time when there is no vaccine or approved treatment option available for the virus, advocates and experts say this kind of marketing is dangerous and could lead people to avoid conventional health care options, putting them at risk.

“The last thing the world needs in these difficult and often confusing times is someone with any level of celebrity using their public platform to sell their personal products on false promises and pseudoscience,” Erik Altieri, executive director of NORML, told Marijuana Moment. “Marijuana and its components do not cure the coronavirus, to say the opposite just to put a few more bucks in your pocket is grotesque. All Americans should be on alert for these modern day charlatans and snake oil salespeople.”

But Turley evidently is undeterred by the criticism. He tweeted on Sunday that “CANNABIS WILL PREVENT & CURE COVID19!!!!!!!” and acknowledged that the statement would elicit “hate.”

In a phone interview with Marijuana Moment on Monday, the athlete-turned-entrepreneur said he has “lots of reasons to believe what I believe and I will continue to proclaim god’s truth in this whole thing because he saved my life through this plant. Period.”

But it’s not a point taken well by allies and opponents of marijuana reform, who’ve widely condemned the claim.

“All I’m saying is that the immune system will kill the coronavirus if you give your immune system cannabis. It will boost it to its levels where it will kill the coronavirus,” Turley said. “In return, it is very feasible and logical for me to back my statements and say CBD will cure and prevent the coronavirus. Why wouldn’t it?”

Turley is promoting a line of CBD products from his company, NEURO XPF, with an ad using the slogan “Crush Corona” along with artistic renditions of the virus. FDA would likely take issue with that kind of advertising, as it’s made clear it will take enforcement action against cannabis companies that make unsubstantiated claims about the therapeutic potential of their products.

The agency has sent several warning letters to such companies over the last year, imploring them to cease making therapeutic claims that aren’e backed up by research.

But as far as Turley is concerned, FDA action would represent an opportunity.

“I welcome it,” he said. “Please shut my company down so I can have another blockbuster press release on how the FDA and the United States government is suppressing truth and information when we have study after study now being driven by major cannabis companies in getting clinical trials to prove what I’m saying is true.”

Several people have commented on Turley’s Twitter posts, encouraging him to stop spreading misinformation about the therapeutic potential of cannabis when it comes to the virus.

In another tweet, Turley appeared to claim that cannabis products are “the cure for cancer.”

The former NFL player also said on Sunday that he would mail free CBD to individuals who reach out with documentation showing that they’ve tested positive for COVID-19. So far, he said, only one person has reached out with a positive test, and that that Louisiana-based individual will receive a full month’s supply of CBD from his company NEURO XPF.

Advocates have been loud and clear that businesses should not promote misleading claims about marijuana in the midst of this pandemic. They’ve further recommended avoiding combustable marijuana products, as the virus targets the respiratory system.

Turley had a simple message for advocates who have rejected his claims: “Cowards. Cowards.”

“I’ve been putting in work on my own dime, on my own time, taking away from my family, to move this conversation forward. And that’s what I’ve done,” he said, adding that they’re “scared to say too much because we don’t want the government, we don’t want the man, to start coming down on us.”

“Well guess what? I was a first round draft pick, I made millions of dollars, god saved my life through this plant and I live in America. So get used to it,” he said. “And I’m going to continue to spread his word.”

DC Activists Have A New Plan To Get Psychedelics Decriminalization On The Ballot Despite Coronavirus

Photo courtesy of Brian Shamblen.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/coronavirus-upends-marijuana-psychedelics-and-drug-reform-ballot-measures/

Comments

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate